Clinical Trial

A Clinical Evaluation of AMJ-401

Recruiting
View on ClinicalTrials.gov →
Summary
A Clinical Evaluation of AMJ-401 in the Treatment of Subjects with Ischemic Heart Disease in Japan
Protocol Amendment History 1 change
notable Trial sites expanded: 1 -> 10 locations 2026-04-08
Trial Details
NCT Number NCT07373353
Lead Sponsor Abbott Medical Devices
Conditions Ischemic Heart Disease (IHD)
Enrollment 50 participants
Start Date 2025-12-17
Primary Completion 2026-12-31 (estimated)
Study Completion 2031-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-07